Lataa...
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
BACKGROUND AND OBJECTIVES: Rates of malignant melanoma are continuing to increase, and until recently effective treatments were lacking. However, since 2011 three immunotherapeutic agents, known as checkpoint inhibitors, have been approved. This review aims to establish whether these three drugs – i...
Tallennettuna:
| Julkaisussa: | Clin Cosmet Investig Dermatol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580705/ https://ncbi.nlm.nih.gov/pubmed/28883738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S120877 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|